Cutler Group’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100
Closed -$1K 6217
2021
Q4
$1K Buy
+100
New +$33.8K ﹤0.01% 5205
2021
Q2
Sell
-1,100
Closed -$162K 6505
2021
Q1
$162K Hold
1,100
0.01% 1420
2020
Q4
$74K Sell
1,100
-900
-45% -$248K ﹤0.01% 1730
2020
Q3
$224K Sell
2,000
-3,600
-64% -$846K 0.01% 864
2020
Q2
$88K Buy
+5,600
New +$912K 0.01% 1389
2020
Q1
Sell
-1,100
Closed -$31K 4791
2019
Q4
$31K Buy
1,100
+800
+267% +$133K ﹤0.01% 1953
2019
Q3
$1K Sell
300
-2,800
-90% -$372K ﹤0.01% 3884
2019
Q2
$16K Buy
3,100
+1,100
+55% +$140K ﹤0.01% 2386
2019
Q1
$7K Buy
2,000
+1,000
+100% +$135K ﹤0.01% 2749
2018
Q4
$11K Sell
1,000
-7,500
-88% -$995K ﹤0.01% 2492
2018
Q3
$58K Buy
8,500
+2,900
+52% +$488K ﹤0.01% 1519
2018
Q2
$5K Buy
5,600
+100
+2% +$17.8K ﹤0.01% 3160
2018
Q1
$145K Buy
5,500
+3,200
+139% +$433K 0.01% 980
2017
Q4
$28K Buy
2,300
+1,300
+130% +$119K ﹤0.01% 2299
2017
Q3
$20K Buy
+1,000
New +$74.5K ﹤0.01% 3153

Other funds holding ONC

Cutler Group's ONC Position: Q1 2023 in Review

Cutler Group sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 714 shares — an estimated $171K sold.

Cutler Group first reported a position in ONC in Q2 2018 and held it in 11 quarters. The position peaked at $421K in Q1 2020. 219 funds tracked by Wall St. Rank hold ONC as of Q1 2023.

  • Cutler Group reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 714 BeOne Medicines Ltd shares in Q1 2023, an estimated $171K.
  • Cutler Group first reported a position in BeOne Medicines Ltd in Q2 2018 and held it in 11 quarters.
  • Cutler Group's BeOne Medicines Ltd position peaked at $421K in Q1 2020.
  • 219 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.